The invention relates to a
Tibetan medicine composite for treating diabetes, comprising the following components: 4.8-7.2g of
medicine terminalia fruit, 2.4-3.6g of Chaxun ointment, 4-6g of
long pepper extract, 3.2-4.8g of bright salt, 4.8-7.2g of
trona, 2.4-3.6g of costustoot, 4-6g of fructus coriandri sativi, 2.4-3.6g of Tibet
inula root, 4.8-7.2g of round cardamom, 4-6g of dried ginger, 2.4-3.6 cortex cinnamomi, 4-6g of red flower, 4-6g of savoury rhododendron leaf, 1.6-2.4g of
pomegranate seed, 2.4-3.6g of rhubarb, 0.8-1.2g of purpurea halitium, 0.8-1.2g of
flos caryophyllata, 4-6g of fructus terminaliae billericae, 1.6-2.4g of Shaji ointment, 2.4-3.6g of emblic leafflower fruit, 0.8-1.2g of
crocus sativus, 0.8-1.2g of bear
gall, 4-6g of fructus tsaoko, 4-6g of siberian solomonseal
rhizome, 2.4-3.6g of puncturevine caltrop fruit, 4.8-7.2g of
embelia laeta, 7.4-9.6g of herba dracocephali tangutici, and 7.4-9.6g of
tinospora sinensis. The
Tibetan medicine composite of the invention has significant
clinical efficacy, little toxic and side effects and simple and convenient preparation.